Features | Partner Sites | Information | LinkXpress
Sign In

Imaging for Amyloid Deposits Also Shows Promise for Detecting Cardiac Amyloidosis

By Medimaging International staff writers
Posted on 21 Feb 2013
Whereas amyloid imaging may now be most associated with detecting plaques in the brain, it also has the potential to alter the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research, positron emission tomography (PET) with 11C-PIB (Pittsburgh compound B) can effectively visualize amyloid deposits in the heart. Currently, there is no other noninvasive test available for specific diagnosis.

The study’s findings were published in the February 2013 issue of the Journal of Nuclear Medicine. Cardiac amyloidosis is a deadly disorder caused by abnormal amyloid deposits in the heart tissue. Early diagnosis before structural change to the heart tissue has occurred is important for disease prognosis and for treatment monitoring. Echocardiography is the current mainstay of imaging in cardiac amyloidosis; a cardiac biopsy is used to validate diagnosis.

“Imaging with 11C-PIB provides a noninvasive and specific means of showing distribution of amyloid in an organ. This gives a unique opportunity to follow and monitor therapy, as amyloid deposits in the heart should decrease with successful therapy,” said Gunnar Antoni, PhD, from department of medicinal chemistry, Uppsala University (Sweden), and lead author of the research.

The study included 10 patients diagnosed with cardiac amyloidosis and five healthy individuals. PET/computed tomography (CT) with 11C-PIB was used to visualize amyloid deposits in the heart and with 11C-acetate to measure myocardial blood flow.

Uptake of 11C-PIB was measured 15–25 minutes after injection. Obvious uptake of 11C-PIB was noted in the left ventricle wall of all patients with cardiac amyloidosis, while no uptake was seen in the healthy volunteers. In half of the patients, 11C-PIB was also detected in the right ventricle wall, and nine of the patients had signs of reversible uptake, with a maximum concentration at 10–15 minutes after injection. Myocardial blood flow was significantly lower in patients with cardiac amyloidosis; however, no significant correlation between myocardial blood flow and 11C-PIB uptake was found.

“This study emphasizes the strength of molecular imaging for detecting an underlying and significant molecular aberration in a disease that presents with unspecific symptoms and signs,” noted Dr. Antoni. “The potential for molecular imaging to provide valuable information for other diseases is of great value to the field of medicine.”

Related Links:
Uppsala University



view channel

Warning from ACP About Overuse of Imaging for Patients with Suspected Pulmonary Embolism

The American College of Physicians (ACP; Philadelphia, PA, USA) has warned that the overuse of Computed Tomography (CT), and D-dimer testing, for suspected Pulmonary Embolism (PE) cases could harm patients and create unnecessary costs, without improving the patient outcome. The ACP suggests that physicians stratify patients... Read more


view channel
Image: New system from MIT and Boston Children’s Hospital that can convert MRI scans into 3-D-printed heart models within a number of hours (Photo courtesy of Bryce Vickmark, MIT News).

Researchers Develop MRI-Derived 3-D-Printed Heart Models for Use in Surgical Planning

Researchers have developed a technique to convert Magnetic Resonance Imaging (MRI) scans into 3-D-printed models of a patient’s heart that takes only a few hours. The models are intended to enable surgeons... Read more


view channel
Image: Color Image Acquired by the Analogic bk5000 Ultrasound Device (Photo courtesy of Analogic).

New Ultrasound System Designed for Surgery Launched in Germany and the US

A new ultrasound system that provides surgeons with real-time guidance in the operating room has been launched. The system was designed for simplicity, speed and image quality, and is intended to assist... Read more

General/Advanced Imaging

view channel

Leading Vendor to Implement and Install Enterprise Imaging Platform for UK NHS

An agreement has been announced by a leading imaging platform provider for the implementation of the first Enterprise Imaging platform, part of a long-term agreement for the management of imaging data, for the UK City Hospitals Sunderland NHS Foundation Trust. The agreement covers the capture, storage, and exchange of... Read more

Imaging IT

view channel

Carestream Updates Healthcare IT Platform

Carestream has released updates for an advanced Internet Technology (IT) healthcare platform at the Röntgenveckan Radiology congress in Malmo (Sweden). The IT platform facilitates collaboration by enabling sharing of critical patient information such as Radiology images, videos, reports, and services with groups outside... Read more

Industry News

view channel

Orthopedic Medical Imaging Pioneer Acquires Exclusive Rights to Scoliosis Prognosis Algorithm

A company that leads in 2-D/3-D orthopedic medical imaging announced that it has acquired the rights to a worldwide license for a 2-D/3-D software that can predict the risk of adolescent patients with mild scoliosis developing severe deformities. The software algorithm uses various clinical parameters obtained from patient... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.